Nanotherapy is revolutionizing cancer treatment. A recent breakthrough in the field of nanotherapy has resulted in the development of fluorescence-guided photoimmunotherapy, or FGPIT, for the treatment of peritoneal carcinomatosis. FGPIT is an innovative treatment that combines nanotechnology, optical imaging, and immunotherapy to target cancer cells. The key to FGPIT is the use of fluorescent nanocarriers which are injected into the body and targeted to cancer cells. These nanocarriers are then exposed to specific light frequencies which activate an immune response and destroy the cancer cells.

This breakthrough in nanotherapy is promising news for those suffering from peritoneal carcinomatosis, an aggressive form of cancer. FGPIT is an effective treatment option that is minimally invasive and has minimal side effects. This nanotherapy could be the key to a successful cancer treatment in the future.

Read Full Article Here

source: Phys.org